HEPATOCELLULAR CANCER
Clinical trials for HEPATOCELLULAR CANCER explained in plain language.
Never miss a new study
Get alerted when new HEPATOCELLULAR CANCER trials appear
Sign up with your email to follow new studies for HEPATOCELLULAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets advanced cancers in early trial
Disease control OngoingThis study tests a new drug called Q702 combined with pembrolizumab (a standard immunotherapy) in people with advanced esophageal, stomach, liver, or cervical cancer that has worsened after prior treatment. The goal is to see if the combination is safe and can shrink tumors or sl…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE1, PHASE2 • Sponsor: Qurient Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:51 UTC
-
New drug cocktail plus targeted procedure shows promise for tough liver cancers
Disease control OngoingThis study tests whether combining three drugs (durvalumab, bevacizumab, tremelimumab) with a liver procedure called TACE can help people with advanced liver or bile duct cancer live longer without their cancer growing. About 27 adults with intermediate or advanced liver cancer o…
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Cancer vaccine trial pulled before it even started
Disease control TerminatedThis study aimed to see if a person's own immune cells, modified in a lab to target specific cancer gene mutations, could prevent gastrointestinal cancers from coming back after standard treatment. It was designed for people with certain gene changes and blood markers suggesting …
Matched conditions: HEPATOCELLULAR CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New blood test could spot liver cancer earlier than ultrasound
Diagnosis OngoingThis study is testing a new blood test called Oncoguard™ Liver to see how well it finds liver cancer early in people who are at high risk, such as those with cirrhosis or hepatitis B. About 2,990 adults will take part, and the test's accuracy will be compared to standard ultrasou…
Matched conditions: HEPATOCELLULAR CANCER
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated May 15, 2026 11:53 UTC
-
10,000 liver cancer patients enrolled in largest Real-World study of its kind
Knowledge-focused OngoingThis study follows 10,000 adults with hepatocellular carcinoma (a type of liver cancer) to see how the disease progresses and how doctors treat it in real-world settings. Researchers will collect information on treatments, side effects, and quality of life over time. The goal is …
Matched conditions: HEPATOCELLULAR CANCER
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 00:47 UTC